BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
See today's BioWorld
Home
» In the clinic for Oct. 27, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
In the clinic for Oct. 27, 2022
Oct. 27, 2022
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelrx, Aileron, Anixa, Astrazeneca, Atara, Biogen, BMS, Boehringer, Cocrystal, Codagenix, Corvus, Covis, Effector, Essa, Exelixis, Foghorn, Hepion, Horizon, Immutep, Jaguar, Kura, Merck, Merus, Morphic, Nurix, Olema, Oncopeptides, Redhill, Ryvu, Viiv.
BioWorld
Briefs
In the clinic
Coronavirus